HAIR-AN syndrome

HAIR-AN syndrome is a medical condition characterized by a combination of hyperandrogenism, insulin resistance, and acanthosis nigricans. It is considered a subset of polycystic ovary syndrome (PCOS) and is often associated with metabolic syndrome.
Signs and Symptoms
The primary features of HAIR-AN syndrome include:
- Hyperandrogenism: Elevated levels of androgens leading to symptoms such as hirsutism, acne, and alopecia.
- Insulin resistance: A condition where the body's cells become less responsive to the hormone insulin, often leading to hyperinsulinemia and an increased risk of type 2 diabetes.
- Acanthosis nigricans: A skin condition characterized by dark, velvety patches in body folds and creases, commonly found in the neck, armpits, and groin.
Pathophysiology
The exact cause of HAIR-AN syndrome is not fully understood, but it is believed to involve a combination of genetic and environmental factors. The condition is often associated with obesity, which can exacerbate insulin resistance and hyperandrogenism.
Diagnosis
Diagnosis of HAIR-AN syndrome typically involves a combination of clinical evaluation, laboratory tests, and imaging studies. Key diagnostic criteria include:
- Elevated levels of androgens in the blood.
- Evidence of insulin resistance, such as elevated fasting insulin levels or abnormal glucose tolerance tests.
- Presence of acanthosis nigricans.
Treatment
Treatment of HAIR-AN syndrome focuses on managing the symptoms and underlying conditions. Common approaches include:
- Lifestyle modifications: Weight loss through diet and exercise can improve insulin sensitivity and reduce androgen levels.
- Medications: Insulin-sensitizing agents such as metformin and anti-androgens like spironolactone may be prescribed.
- Cosmetic treatments: Options such as laser hair removal and topical treatments for acne and acanthosis nigricans.
Prognosis
With appropriate management, many individuals with HAIR-AN syndrome can achieve significant improvement in symptoms. However, the condition requires ongoing monitoring and treatment to prevent complications such as type 2 diabetes and cardiovascular disease.
Related Pages
- Polycystic ovary syndrome
- Hyperandrogenism
- Insulin resistance
- Acanthosis nigricans
- Metabolic syndrome
- Type 2 diabetes
Categories
This endocrine system related article is a stub.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian